A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.
- Citation:
- J Thorac Oncol vol 15 (1) 110-9
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 9
- Parents:
- 960
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Neotropix, Inc
- Grants:
- U10CA180821, U10CA180882, U10CA180866, U10CA180790, U10CA180791, U10CA233196, U10CA233290, U10CA180820, UG1CA189952, U10CA180888
- Corr. Author:
- Authors:
- Erin L Schenk Sumithra J Mandrekar Grace K Dy Marie Christine Aubry Angelina D Tan Shaker R Dakhil Bradley A Sachs Jorge J Nieva Erin Bertino Christine Lee Hann Steven E Schild Troy W Wadsworth Alex A Adjei Julian R Molina
- Networks:
- CA011, KS055, LAPS-CO070, LAPS-MD017, LAPS-MN026, LAPS-NY158, OH008, WA030
- Study
- NCCTG-N0923
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: